HOPA/ONS TIL Webinar Series
HOPA and the Oncology Nursing Society (ONS) have collaborated on a series of three webinars, all focused on sharing knowledge about tumor-infiltrating lymphocyte (TIL) therapy for people with advanced melanoma and the logistics of bringing TIL therapy to patients.
The second 60-minute webinar session - "Keep Working TIL We Beat Melanoma! The Operations and Science Behind TIL Therapy" - will go live Tuesday, October 29, 2024. There is 1.0 CE credit available for Webinar #2.
Learning Opportunities
-
Individual
Webinar #2: Keep Working TIL We Beat Melanoma! The Operations and Science Behind TIL Therapy
Live Join us for the second of a three-part webinar discussion series, regarding FDA-approved TIL therapy for melanoma, operationalizing TIL therapy, and the science and side effects. Learn more